BioSenic provides update on its autoimmune disease platform based on ATO

BIOSENIC Euronext Brussels and Paris: BIOS), the company specialized in serious autoimmune inflammatory diseases and cell repair, today announces an update on its systemic autoimmune disease... | November 9, 2022

Related Keywords

Boston ,Massachusetts ,United States ,Dana Farber Cancer Institute ,Paris ,France General ,France ,Francois Rieger ,Corey Cutler ,Catherine Haquenne ,Ann Reum ,Medsenic Biosenic ,Harvard Medical School ,Stem Cell Transplantation Program ,Euronext Brussels ,Host Disease ,Arsenic Trioxide ,Farber Cancer Institute ,Graft Versus Host ,Market Access ,Chronic Graft ,Systemic Lupus ,Systemic Sclerosis ,News Publishing ,Biosenic Sa Stock Exchange ,News ,Information ,Press Release ,Biosenic ,Uronext ,Brussels ,End ,The ,Company ,Specialized ,N ,Serious ,Autoimmune ,Inflammatory ,Diseases ,Fell ,Oday ,Nnounces ,Update ,Its ,Systemic ,Utoimmune Bios Be0974280126 ,